Tranquility Research

Webster, Texas 77598

1 studies enrolling now · 9 studies all time

What they study most

Atopic Dermatitis, Breast Neoplasms, CKD, COVID-19, Focal Segmental Nephrosis, Glomerulonephritis, Glomerulosclerosis, Kidney Diseases, Lipoid Urologic Disease, Neoplasm Metastasis, Nephritis, Nephrosis

Studies at this site

• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study) — Recruiting now
• A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes — Completed
• EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) — Completed
• Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept — Completed
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection — Completed
• An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases — Stopped early